Erik Martens

3.6k total citations
89 papers, 2.5k citations indexed

About

Erik Martens is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Erik Martens has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Immunology and 28 papers in Cancer Research. Recurrent topics in Erik Martens's work include Protease and Inhibitor Mechanisms (28 papers), Cell Adhesion Molecules Research (10 papers) and Peptidase Inhibition and Analysis (8 papers). Erik Martens is often cited by papers focused on Protease and Inhibitor Mechanisms (28 papers), Cell Adhesion Molecules Research (10 papers) and Peptidase Inhibition and Analysis (8 papers). Erik Martens collaborates with scholars based in Belgium, Germany and United Kingdom. Erik Martens's co-authors include Ghislain Opdenakker, Philippe E. Van den Steen, Paul Proost, Jennifer Vandooren, Nathalie Geurts, Veerle Janssens, Jozef Goris, Francis J. Descamps, Alfons Billiau and Christine Van Hoof and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Erik Martens

88 papers receiving 2.5k citations

Peers

Erik Martens
Katherine A. Owen United States
Vasu Punj United States
Paul Waring Australia
Andrew E. Parker United Kingdom
Paul Coughlin Australia
Paula Fernández Switzerland
Joseph Barbi United States
Matthew F. Starost United States
Katherine A. Owen United States
Erik Martens
Citations per year, relative to Erik Martens Erik Martens (= 1×) peers Katherine A. Owen

Countries citing papers authored by Erik Martens

Since Specialization
Citations

This map shows the geographic impact of Erik Martens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Martens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Martens more than expected).

Fields of papers citing papers by Erik Martens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Martens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Martens. The network helps show where Erik Martens may publish in the future.

Co-authorship network of co-authors of Erik Martens

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Martens. A scholar is included among the top collaborators of Erik Martens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Martens. Erik Martens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cambier, Seppe, Noëmie Pörtner, Mieke Metzemaekers, et al.. (2023). Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients. Cellular and Molecular Life Sciences. 80(8). 234–234. 6 indexed citations
2.
Berghmans, Nele, Sam Noppen, Erik Martens, et al.. (2022). A stabilized CXCL9(74–103)-derived peptide selectively inhibits proliferation, adhesion and metastasis of tumor cells that express high levels of heparan sulfate. International Journal of Biological Macromolecules. 222(Pt B). 2808–2822. 3 indexed citations
3.
Pereira, Rafaela Vaz Sousa, Estefanía Ugarte-Berzal, Jennifer Vandooren, et al.. (2022). Chlorite-Oxidized Oxyamylose (COAM) Has Antibacterial Activity and Positively Affects Skin Wound Healing. Journal of Inflammation Research. Volume 15. 4995–5008. 1 indexed citations
4.
Ugarte-Berzal, Estefanía, Erik Martens, Olivia Cano‐Garrido, et al.. (2020). Recombinant Protein-Based Nanoparticles: Elucidating Their Inflammatory Effects In Vivo and Their Potential as a New Therapeutic Format. Pharmaceutics. 12(5). 450–450. 7 indexed citations
5.
Seras‐Franzoso, Joaquin, Diana Rafael, Fernanda Andrade, et al.. (2020). The Biological Potential Hidden in Inclusion Bodies. Pharmaceutics. 12(2). 157–157. 19 indexed citations
6.
Bruyn, Magali de, Erik Martens, Marc Ferrante, et al.. (2018). OP007 Detection of mucosal healing with a serum marker panel in adalimumab-treated patients with ulcerative colitis. Journal of Crohn s and Colitis. 12(supplement_1). S005–S005. 1 indexed citations
7.
Ugarte-Berzal, Estefanía, Nele Berghmans, Louis Boon, et al.. (2018). Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis. PLoS ONE. 13(10). e0197944–e0197944. 11 indexed citations
8.
Gounko, Natalia V., Erik Martens, Ghislain Opdenakker, & Vasily Rybakin. (2016). Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B. Scientific Reports. 6(1). 29852–29852. 5 indexed citations
9.
Breynaert, Christine, Magali de Bruyn, Ingrid Arijs, et al.. (2016). Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis. Journal of Crohn s and Colitis. 10(11). 1336–1350. 38 indexed citations
10.
Berghmans, Nele, Hubertine Heremans, Sandra Li, et al.. (2012). Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes. Journal of Neuroinflammation. 9(1). 243–243. 18 indexed citations
11.
Piccard, Heléne, Nele Berghmans, Éva Korpos, et al.. (2011). Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function. International Journal of Cancer. 131(4). E425–36. 8 indexed citations
12.
Piccard, Heléne, Jialiang Hu, Pierre Fiten, et al.. (2009). “Reverse degradomics”, monitoring of proteolytic trimming by multi‐CE and confocal detection of fluorescent substrates and reaction products. Electrophoresis. 30(13). 2366–2377. 11 indexed citations
13.
Cauwe, Bénédicte, Erik Martens, Philippe E. Van den Steen, et al.. (2008). Adenylyl cyclase-associated protein-1/CAP1 as a biological target substrate of gelatinase B/MMP-9. Experimental Cell Research. 314(15). 2739–2749. 20 indexed citations
14.
Descamps, Francis J., Dustan Kangave, Bénédicte Cauwe, et al.. (2008). Interphotoreceptor retinoid‐binding protein as biomarker in systemic autoimmunity with eye inflictions. Journal of Cellular and Molecular Medicine. 12(6a). 2449–2456. 15 indexed citations
15.
Descamps, Francis J., Erik Martens, Dustan Kangave, et al.. (2006). The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage. Experimental Eye Research. 83(2). 401–407. 37 indexed citations
16.
Martens, Erik, Ilse Stevens, Veerle Janssens, Jozef Goris, & Christine Van Hoof. (2003). Genomic structure of the mouse PP2A/PR61 genes and their developmental regulation and tissue distribution. FEBS Journal. 154–154. 1 indexed citations
17.
Jaspersen, D, et al.. (1999). Diagnostischer Omeprazoltest bei Verdacht auf refluxassoziierten chronischen Husten. Pneumologie. 53(9). 438–441. 8 indexed citations
18.
Heremans, Hubertine, Chris Dillen, Marleen Groenen, Erik Martens, & Alfons Billiau. (1996). Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon‐γ. European Journal of Immunology. 26(10). 2393–2398. 112 indexed citations
19.
Paemen, Liesbet, Erik Martens, Koen Norga, et al.. (1996). The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. Biochemical Pharmacology. 52(1). 105–111. 90 indexed citations
20.
Billiau, Alfons, Patrick Matthys, Erik Martens, & Hubertine Heremans. (1994). Effects of Anti-Interferon-γ and Anti-Interleukin-6 Antibodies in Disease Models in Mice: Antibodies as Carriers of Cytokines. Journal of Interferon Research. 14(5). 277–279. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026